Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Duanbo Shi"'
Autor:
Song Li, Wenbin Yu, Fei Xie, Haitao Luo, Zhimin Liu, Weiwei Lv, Duanbo Shi, Dexin Yu, Peng Gao, Cheng Chen, Meng Wei, Wenhao Zhou, Jiaqian Wang, Zhikun Zhao, Xin Dai, Qian Xu, Xue Zhang, Miao Huang, Kai Huang, Jian Wang, Jisheng Li, Lei Sheng, Lian Liu
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-16 (2023)
Immune checkpoint inhibitors and antiangiogenic agents have shown some activity in patients with late-stage gastric cancer. Here the authors report the results of a phase II trial of neoadjuvant anti-PD1 (camrelizumab), antiangiogenic agent (apatinib
Externí odkaz:
https://doaj.org/article/a4e190d3b92f4b949cc25d4b09eb4a42
Publikováno v:
Annals of Surgical Oncology. 30:3594-3602
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8a7777e5c592effb5df88a4c0b8c212
https://doi.org/10.1245/s10434-023-13143-w
https://doi.org/10.1245/s10434-023-13143-w
Publikováno v:
Annals of Surgical Oncology. 30:3603-3604
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f303958fb4b09515f1f197de6b9e8cb9
https://doi.org/10.1245/s10434-023-13240-w
https://doi.org/10.1245/s10434-023-13240-w
Autor:
Xiao Wang, Yiting Sun, Duanbo Shi, Lanbo Li, Di Zhang, Cheng Chen, Lian Liu, Zeyi Zhao, Teng Liu, Jing Gao, Wenbin Yu, Song Li
Publikováno v:
Journal of Cancer
CD148 is a member of the receptor-type protein tyrosine phosphatase family encoded by the PTPRJ gene and has controversial impacts on cancers. In this study, we investigated the clinical significance of CD148 in gastric cancer and the possible mechan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7822492a6d40dd3d901a486ecb24ff1
https://pubmed.ncbi.nlm.nih.gov/32201537
https://pubmed.ncbi.nlm.nih.gov/32201537
Autor:
Jing Gao, Meng Wei, Fei Xie, Wei-Wei Lv, Lian Liu, Song Li, Wenbin Yu, Lei Sheng, Jiaqian Wang, Zhimin Liu, Zhikun Zhao, Cheng Chen, Dexin Yu, Yongtian Zhao, Duanbo Shi
Publikováno v:
Journal of Clinical Oncology. 39:4061-4061
4061 Background: The prognosis of cT4a/bN+ gastric cancer (GC) is poor due to low R0 resection rate and frequent recurrence. We evaluated the feasibility, safety, and efficacy of a combination of immunotherapy, anti-angiogenesis, and chemotherapy for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::44bbe9d0b5ab83546f3e858cf0f20c03
https://doi.org/10.1200/jco.2021.39.15_suppl.4061
https://doi.org/10.1200/jco.2021.39.15_suppl.4061